Clinical Trials on Tidel Volume Challenge Test in New Zealand
Total 0 results
Nothing found
Sponsors and Collaborators
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- Centro di Procreazione Assistita Demetra
- Bjørgene Omsorgssenter, Haugesund
- BayCare Health System
- Veeda Oncology
- Chengdu Nuoen Biotechnologies, Inc.
- Prestige Biopharma Limited
- North Karelia Hospital District
- Grand Challenges Canada
- Mononuclear Therapeutics Ltd.
- InflaRx GmbH
- ImproveCareNow (ICN)
- Reina Sofia University Hospital
- Equipe MiMes
- Maria Lendorf
- AIDS Council of New South Wales
- Nestor Soler Porcar, MD, PhD
- Neuregenix
- Bruce County Paramedic Service
- Women and children's hospital of Jiaxing university
- View Full List
Medical Conditions
- Skull Base Neoplasms
- Gullian Barre Syndrome
- Predictors of Atrial Fibrillation Recurrences
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Psoriasis, Arthritic
- Chlamydophila Infections
- Pulmonary Adenocarcinoma
- Painless Hysteroscopy
- Epidemic Hemorrhagic Fever
- Fetus or Neonate Affected by External Version Before Labor
- Tay-Sachs Disease Ganglioside
- Multisystem Proteinopathy
- Ewing's Family Tumors
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Endocarditis Infective
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Closure; Foramen Ovale
- Fracture Dislocation of Cervical Spine
- Childhood Langerhans Cell Histiocytosis
- Spine Surgeries
- View Full List
Drug Interventions
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- High dose pantoprazole infusion
- EFV +TVA
- Redifferentiation with retinoid acid
- Azelastine hydrochloride (BAYR9258)
- Qingkailing injection 40 ml
- Semapimod
- Palliative care group first-line scheme
- Neihulizumab
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Estradiol+Drospirenone
- Esomeprazole 40mg before
- Vehicle
- Cereport
- Adriamycin
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Glimepiride
- Chemotherapeutic Agent
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Adapalene Gel 0.3%
- View Full List
CROs by country
- Contract Research Organizations in Brazil
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Colombia
- Contract Research Organizations in Denmark
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in France
- Contract Research Organizations in Latvia
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Panama
- Contract Research Organizations in Peru
- Contract Research Organizations in Spain
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Tanzania
- CRO list by country